Literature DB >> 10803753

Calcium crystal effects on the cells of the joint: implications for pathogenesis of disease.

H S Cheung1.   

Abstract

In the past three years, there has been considerable progress in delineating the mechanism of calcium-containing crystal-induced cell activation: (1) the identification of Ca2+ influx and p42/44 mitogen-activated protein kinase activation as the signal transduction pathways; (2) induction of nuclear transcription factors of cyclic adenosine monophosphate (cAMP) response element binding protein, activator protein-1, and nuclear factor kappaB; (3) the differential role of crystal endocytosis and dissolution in crystal-induced metalloproteinase synthesis and mitogenesis; (4) crystal upregulation of matrix metalloproteinases, including MMP-13 but downregulation of tissue inhibitor of metalloproteinase-1 and -2, thus magnifying the degenerative effect of crystals. Phosphocitrate, a specific inhibitor of biologic effect of calcium crystals, reverses the degenerative effects of crystals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803753     DOI: 10.1097/00002281-200005000-00012

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  12 in total

1.  Chondrocalcinosis, osteophytes and osteoarthritis.

Authors:  K D Brandt
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

Review 2.  Crystals, inflammation, and osteoarthritis.

Authors:  Ann K Rosenthal
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

3.  4 T MRI of chondrocalcinosis in combination with three-dimensional CT, radiography, and arthroscopy: a report of three cases.

Authors:  J C Suan; R K Chhem; J S Gati; C J Norley; D W Holdsworth
Journal:  Skeletal Radiol       Date:  2005-09-16       Impact factor: 2.199

4.  Osteopontin promotes pathologic mineralization in articular cartilage.

Authors:  Ann K Rosenthal; Claudia M Gohr; Miwa Uzuki; Ikuko Masuda
Journal:  Matrix Biol       Date:  2006-10-20       Impact factor: 11.583

Review 5.  Calcium pyrophosphate dihydrate and basic calcium phosphate crystal-induced arthropathies: update on pathogenesis, clinical features, and therapy.

Authors:  Hang-Korng Ea; Frédéric Lioté
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

6.  Dexamethasone promotes calcium pyrophosphate dihydrate crystal formation by articular chondrocytes.

Authors:  Mark Fahey; Elizabeth Mitton; Emily Muth; Ann K Rosenthal
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

7.  Chondrocalcinosis is associated with increased knee joint degeneration over 4 years: data from the Osteoarthritis Initiative.

Authors:  S C Foreman; A S Gersing; C E von Schacky; G B Joseph; J Neumann; N E Lane; C E McCulloch; M C Nevitt; T M Link
Journal:  Osteoarthritis Cartilage       Date:  2019-10-17       Impact factor: 6.576

8.  Octacalcium phosphate crystals directly stimulate expression of inducible nitric oxide synthase through p38 and JNK mitogen-activated protein kinases in articular chondrocytes.

Authors:  Hang-Korng Ea; Benjamin Uzan; Christian Rey; Frédéric Lioté
Journal:  Arthritis Res Ther       Date:  2005-05-27       Impact factor: 5.156

9.  Functional analysis of an arthritogenic synovial fibroblast.

Authors:  Vassilis Aidinis; David Plows; Sylva Haralambous; Maria Armaka; Petros Papadopoulos; Maria Zambia Kanaki; Dirk Koczan; Hans Juergen Thiesen; George Kollias
Journal:  Arthritis Res Ther       Date:  2003-03-14       Impact factor: 5.156

10.  Phosphocitrate is potentially a disease-modifying drug for noncrystal-associated osteoarthritis.

Authors:  Yubo Sun; David R Mauerhan; Atiya M Franklin; James Norton; Edward N Hanley; Helen E Gruber
Journal:  Biomed Res Int       Date:  2013-02-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.